Article info
PDFEditorial
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
- Correspondence to Professor John D Isaacs, Newcastle University Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne NE2 4HH, UK; john.isaacs{at}newcastle.ac.uk
Citation
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
Publication history
- Received May 16, 2020
- Revised May 30, 2020
- Accepted May 30, 2020
- First published June 11, 2020.
Online issue publication
May 15, 2023
Article Versions
- Previous version (13 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage